Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8 + T lymphocyte activation

Author： Rafati S.   Kariminia A.   Seyde-Eslami S.   Narimani M.   Taheri T.   Lebbatard M.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.19, 2002-06, pp. : 2439-2447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis

By Pinto E.F.   de Mello Cortezia M.   Rossi-Bergmann B.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3534-3541

Elsevier

Access to resources Recommend Favorite

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

By Paraguai de Souza E.   Bernardo R.R.   Palatnik M.   Palatnik de Sousa C.B.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3104-3115

Elsevier

Access to resources Recommend Favorite

DNA vaccines induce partial protection against Leishmania mexicana

By Dumonteil E.   Maria Jesus R.-S.   Javier E.-O.   Maria del Rosario G.-M.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2170-2177

Elsevier

Access to resources Recommend Favorite

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

By Rafati S.   Salmanian A.-H.   Taheri T.   Vafa M.   Fasel N.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3369-3375

Elsevier

Access to resources Recommend Favorite

Long-term protection of mice against Leishmania major with a synthetic peptide vaccine

By Spitzer N.   Jardim A.   Lippert D.   Olafson R.W.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1298-1300

Elsevier

Access to resources Recommend Favorite